tazobactam has been researched along with Agranulocytosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
De Ponti, F; Gatti, M; Raschi, E | 1 |
1 other study(ies) available for tazobactam and Agranulocytosis
Article | Year |
---|---|
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Pancytopenia; Pharmacovigilance; Retrospective Studies; Tazobactam | 2021 |